+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compounded or confused? Bioidentical hormones and menopausal health



Compounded or confused? Bioidentical hormones and menopausal health



Menopause International 17(1): 16-18



The aim of this article is to focus on compounded bioidentical hormone (BH) formulations for menopausal symptoms and to discuss the impact of these on women's choice of treatment. The practice of compounding BHs for individualized treatment of women with menopausal symptoms has developed in the USA. In spite of claims of superiority, there is no evidence to suggest that these formulations are any more efficacious or safe than conventional hormone replacement therapy (HRT). In fact, there are some concerns about dosing inconsistencies and usefulness of saliva testing that is carried out as part of this type of treatment. While there should be no serious safety issues for women, there is a mismatch between the reality of compounded BH formulations and women's perception of them.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269293

Download citation: RISBibTeXText

PMID: 21427420

DOI: 10.1258/mi.2011.011009


Related references

Use of bioidentical compounded hormones for menopausal concerns: cross-sectional survey in an academic menopause center. Journal of Women's Health 20(4): 559-565, 2011

What are bioidentical hormones? Natural. Bioidentical. Compounded. Confusion about these terms is only adding to the confusion over hormone therapy. Harvard Women's Health Watch 13(12): 1-3, 2006

Compounded bioidentical menopausal hormone therapy. Fertility and Sterility 98(2): 308-312, 2012

Committee opinion No. 532: compounded bioidentical menopausal hormone therapy. Obstetrics and Gynecology 120(2 Pt 1): 411-415, 2014

Bioidentical hormones. The bottom line on compounded hormones. Mayo Clinic Women's Healthsource 9(9): 1-2, 2005

BMS statement on custom-compounded 'bioidentical hormones'. Post Reproductive Health 23(3): 149-149, 2017

ACOG Committee Opinion #322: Compounded bioidentical hormones. Obstetrics and Gynecology 106(5 Pt 1): 1139-1140, 2005

Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making. Bmc Women's Health 17(1): 97, 2017

Misconception and concerns about bioidentical hormones used for custom-compounded hormone therapy. Journal of Clinical Endocrinology and Metabolism 97(3): 756-759, 2012

Bioidentical compounded hormones: a pharmacokinetic evaluation in a randomized clinical trial. Maturitas 74(4): 375-382, 2013

Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement. Journal of Clinical Endocrinology and Metabolism 101(4): 1318-1343, 2017

Bioidentical hormones for menopausal therapy. Women's Health 4(2): 163-171, 2008

Bioidentical hormones for menopausal hormone therapy: variation on a theme. Journal of General Internal Medicine 22(7): 1030-1034, 2007

Bioidentical hormones: panacea for menopausal hormonal therapy or bio-beware?. South Dakota Medicine 61(7): 244-245, 2008

Bioidentical hormones, menopausal women, and the lure of the "natural" in U.S. anti-aging medicine. Social Science and Medicine 132: 79-87, 2015